Understanding how enterococcus bacteria cause heart infections
Part of Heart & circulation, Infections clinical trials.
This study looks at why some people with enterococcus bacteria in their blood develop a serious heart infection called endocarditis. Researchers want to learn more about this bacteria to help prevent and treat heart infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You can give your own permission to join the study
- You have health insurance (social security)
- You are in the hospital with a positive blood test for enterococcus faecalis bacteria and doctors can't find how it got into your blood
- You started antibiotics less than 48 hours ago
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have heart surgery to treat a serious heart infection called infective endocarditis. It helps doctors learn more about how these surgeries work and what affects recovery.
This study tests whether giving iron and a blood-boosting medicine (EPO) helps patients with bacterial heart valve infections who have low red blood cells. The goal is to see if it speeds recovery and improves how patients feel.
This trial tests whether a treatment without rifampin works as well as one with rifampin for a type of heart valve infection caused by staph bacteria. It aims to find a simpler and safer option for patients with an infected artificial heart valve.
This study gathers information from patients with a heart infection called endocarditis to help doctors better understand and treat the condition. Anyone aged 16 or older with confirmed or suspected endocarditis who is being treated at Barts Heart Centre may be able to join.
This study tests a new way to find the cause of infective endocarditis, a serious heart infection. It may help doctors choose the right treatment faster.
This study looks at blood and other lab test results (“biomarkers”) to better predict what may happen to people with infective endocarditis, a serious infection of the heart lining or heart valves. Your information may help doctors estimate risk and choose care more safely and effectively.
Hear when a new Infective Endocarditis (IE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.